Nicole Bechmann Selected Research

Nicole Bechmann Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 01/2014
18	Pheochromocytoma 04/2024 - 05/2018
15	Paraganglioma (Paragangliomas) 04/2024 - 12/2018
8	Hypoxia (Hypoxemia) 12/2023 - 04/2019
6	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2019
4	Neuroblastoma 01/2024 - 04/2020
3	COVID-19 10/2023 - 01/2022
2	Hypertension (High Blood Pressure) 04/2024 - 02/2022
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 01/2024
2	Disease Progression 01/2024 - 11/2023
2	Adenoma (Adenomas) 08/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 09/2021 - 11/2018
2	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2019
1	Pain (Aches) 04/2024
1	Thyroid Neoplasms (Thyroid Cancer) 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 12/2023
1	Type 2 Diabetes Mellitus (MODY) 09/2023
1	Adrenocortical Carcinoma 08/2023
1	Adrenocortical Adenoma (Disease, Conn's) 08/2023
1	Obesity 01/2023
1	Hyperplasia 01/2023
1	Overweight 01/2023
1	Non-alcoholic Fatty Liver Disease 05/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022
1	Parkinson Disease (Parkinson's Disease) 05/2022
1	Hematuria 02/2022
1	Residual Neoplasm 02/2022
1	Intraoperative Complications 02/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pathologic Processes 01/2022

Drug/Important Bio-Agent (IBA)

13	CatecholaminesIBA 04/2024 - 04/2019
5	Phosphotransferases (Kinase)IBA 03/2024 - 11/2020
4	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 10/2020
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2021
4	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2023 - 12/2018
4	3-methoxytyramine (methoxytyramine)IBA 01/2022 - 10/2020
3	NormetanephrineIBA 01/2022 - 10/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2021
2	Radioisotopes (Radionuclides)IBA 01/2024 - 11/2023
2	Sunitinib (Sutent)FDA Link 11/2023 - 01/2022
2	KynurenineIBA 09/2023 - 06/2021
2	AldosteroneIBA 08/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2021
2	FumaratesIBA 01/2023 - 05/2021
2	Succinic Acid (Succinate)IBA 01/2023 - 01/2021
2	Phenylethanolamine N-MethyltransferaseIBA 05/2022 - 11/2021
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022 - 11/2021
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 04/2019
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	AlpelisibIBA 01/2022 - 11/2019
2	Everolimus FDA Link 01/2022 - 11/2019
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022 - 01/2019
2	Hormones (Hormone)IBA 11/2021 - 04/2021
2	aeroplysinin IIBA 04/2020 - 05/2018
2	isofistularin-3IBA 04/2020 - 05/2018
1	CannabinoidsIBA 04/2024
1	CannabidiolIBA 04/2024
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2024
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2024
1	Mitogen-Activated Protein KinasesIBA 12/2023
1	Tyrosine Kinase InhibitorsIBA 11/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	Dacarbazine (DIC)FDA LinkGeneric 11/2023
1	Temozolomide (Temodar)FDA LinkGeneric 11/2023
1	Vincristine (Oncovin)FDA LinkGeneric 11/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2023
1	somatostatin receptor 2IBA 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	CarbonIBA 01/2023
1	CateninsIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	Testosterone (Sustanon)FDA Link 08/2022
1	PolyaminesIBA 05/2022
1	GlucocorticoidsIBA 05/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2022
1	selpercatinibIBA 01/2022
1	entinostat (MS 275)IBA 01/2022
1	N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA 01/2022
1	niraparibIBA 01/2022
1	cabozantinibIBA 01/2022
1	trametinibIBA 01/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2022
1	Lactate Dehydrogenase 5IBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Homovanillic AcidIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	VaccinesIBA 01/2022

Therapy/Procedure

12	Therapeutics 04/2024 - 01/2019
2	Radiotherapy 01/2021 - 01/2014
1	Drug Therapy (Chemotherapy) 11/2023
1	Immunotherapy 01/2023
1	Cystectomy 02/2022
1	Blood Component Removal (Apheresis) 01/2022